FdaApplication
NDA 201849
Identifiers
- fda_app_no: NDA201849
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | NDA |
| approval_date | 2015-05-08 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GLUCAGON | GLUCAGON HYDROCHLORIDE | EQ 1MG BASE/VIAL | POWDER;INTRAMUSCULAR, INTRAVENOUS |
| GLUCAGON | GLUCAGON HYDROCHLORIDE | EQ 1MG BASE/VIAL | POWDER;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
2 products